Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
The Journal of Urology
|
April 22, 2015
Editorial Comment
Christopher A Warlick
Cancer
|
June 12, 2014
Multiparametric MRI for prostate cancer: seeing is believing
Christopher A Warlick
The World Journal of Men'S Health
|
September 1, 2018
The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
Niranjan J Sathianathen, Christopher A Warlick
Cancer Journal (Sudbury, Mass.)
|
July 22, 2017
Early Stage Cancer in Older Adults: Prostate-Avoiding Overtreatment and Undertreatment
Vikram Narayan, Song Jiang, Christopher A Warlick
Urology
|
December 20, 2005
Keeping childhood sexual abuse on the urologic radar screen
Christopher A Warlick, Ranjiv Mathews, Arlene C Gerson
Urologic Oncology
|
January 18, 2006
Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy
Christopher A Warlick, Mohamad E Allaf, H Ballentine Carter
Research and Reports in Urology
|
February 10, 2025
Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy
Christopher A Warlick, Benjamin D Spilseth, Christopher M Dixon
Urology Practice
|
June 11, 2019
Impact of a Prostate Specific Antigen Screening Decision Aid on Clinic Function
Christopher A Warlick, Jerica M Berge, Yen-Yi Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 26, 2001
In vivo selection of antifolate-resistant transgenic hematopoietic stem cells in a murine bone marrow transplant model
Christopher A Warlick, Michaeleen D Diers, John E Wagner, et al.
Immunological Investigations
|
September 9, 2022
Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials
Daniela F Ward Grados, Hamed Ahmadi, Thomas S Griffith, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
The Journal of Urology
|
April 22, 2015
Editorial Comment
Christopher A Warlick
Cancer
|
June 12, 2014
Multiparametric MRI for prostate cancer: seeing is believing
Christopher A Warlick
The World Journal of Men'S Health
|
September 1, 2018
The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
Niranjan J Sathianathen, Christopher A Warlick
Cancer Journal (Sudbury, Mass.)
|
July 22, 2017
Early Stage Cancer in Older Adults: Prostate-Avoiding Overtreatment and Undertreatment
Vikram Narayan, Song Jiang, Christopher A Warlick
Urology
|
December 20, 2005
Keeping childhood sexual abuse on the urologic radar screen
Christopher A Warlick, Ranjiv Mathews, Arlene C Gerson
Urologic Oncology
|
January 18, 2006
Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy
Christopher A Warlick, Mohamad E Allaf, H Ballentine Carter
Research and Reports in Urology
|
February 10, 2025
Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy
Christopher A Warlick, Benjamin D Spilseth, Christopher M Dixon
Urology Practice
|
June 11, 2019
Impact of a Prostate Specific Antigen Screening Decision Aid on Clinic Function
Christopher A Warlick, Jerica M Berge, Yen-Yi Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 26, 2001
In vivo selection of antifolate-resistant transgenic hematopoietic stem cells in a murine bone marrow transplant model
Christopher A Warlick, Michaeleen D Diers, John E Wagner, et al.
Immunological Investigations
|
September 9, 2022
Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials
Daniela F Ward Grados, Hamed Ahmadi, Thomas S Griffith, et al.
Page
of 3